Woodline Partners »

Mbx Biosciences shares owned by Woodline Partners

Quarter-by-quarter ownership of Mbx Biosciences shares owned by Woodline Partners from 13F filings

Historical chart of Woodline Partners investment in Mbx Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Mbx Biosciences held by Woodline Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Mbx Biosciences by Woodline Partners

Quarter filed Position value Share count Share price at filing
2024-09-30 $14M 520k 25.98

More positions owned by Woodline Partners

Meta Platforms Cl A (META)
Gilead Sciences (GILD)
Abbvie (ABBV)
Revolution Medicines (RVMD)
Vaxcyte (PCVX)
Asml Holding N V N Y Registry Shs (ASML)
Nuvalent Inc-a (NUVL)
Permian Resources Corp Class A Com (PR)
Encana Corporation (OVV)
Keysight Technologies (KEYS)
Danaher Corporation (DHR)
Aon Shs Cl A (AON)
Stmicroelectronics N V Ny Registry (STM)
Regeneron Pharmaceuticals (REGN)
EQT Corporation (EQT)

View all positions for Woodline Partners

Top funds holding Mbx Biosciences

Frazier Life Sciences Management
OrbiMed Advisors
NEA Management Company
NVP Associates
RA Capital Management
T. Rowe Price Associates
Driehaus Capital Management
Woodline Partners
Franklin Resources
Alyeska Investment Group
Platinum Investment Mangement
Citadel Advisors
Stempoint Capital
Monashee Investment Management
TD Asset Management

View all funds holding Mbx Biosciences